[Generalized anxiety disorder: psychosomatic aspects and treatment approaches].
Psychosomatic presentations of generalized anxiety disorder (GAD) and an estimation of efficacy of adaptol in the treatment of patients with this pathology have been studied. The results of clinical examination of 67 patients with GAD , aged from 18 to 45 years, are presented. Adaptol was administered in dose 1500 mg daily during 60 days in 35 patients. The improvement was noted in 68,6% of cases. The high clinical efficacy of adaptol and the absence of side-effects are reported.
L S
LS
Chutko
A V
AV
Rozhkova
V A
VA
Sidorenko
S Iu
SIu
Surushkina
K B
KB
Tursunova
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D001736:Biureas / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D014151:Anti-Anxiety Agents; D001736:Biureas; C015979:mebikar